ABCL (AbCellera Bio) Bozor qiymatining balans qiymatiga nisbati
AbCellera Biologics (ABCL) immunologik dori vositalarini ishlab chiqadi, biroq ta'minot zanjiridagi uzilishlar va savdo to'siqlariga nisbatan zaiflik o'sishni cheklamoqda, bu esa 4.40 dagi aktivning narxlar grafigida aks etgan. Kompaniyaning moliyaviy barqarorligi antitelolarga to'lovlar va hamkorlarining muvaffaqiyatiga bog'liq. Hozirda biznes o'z strategiyasini o'zgartirmoqda va shunchaki huquqlarni sog'liqni saqlash gigantlariga o'tkazish o'rniga, dori vositalarini mustaqil ravishda bozorga olib chiqishni maqsad qilgan.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ABCL_-_AbCellera-Biologics_-_Market-Capitalization-to-Net-Assets "ABCL AbCellera Biologics Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
abcellera.com (ABCL) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati AbCellera|ABCL - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AbCellera Corp|ABCL - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari AbCellera
Kompaniyaning dastlabki tahlili:AbCellera Biologics Inc - ABCL
AI laboratoriyalari va CRO gigantlari bilan qattiq raqobat sharoitida AbCellera Biologics (ABCL) muvaffaqiyati uning intellektual aktivlarining bozor tomonidan tan olinishiga bog'liq. Tarixiy bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini tahlil qilish joriy bozor qiymatini moddiy kapital bilan solishtirish imkonini beradi, bu esa spekulyativ haddan tashqari baholash darajasini va investitsiya sikli o'zgarishi paytida narxlar qulashi xavfini ochib beradi.
Asosiy raqobatchilar
argenx SE (ARGX) - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Tourmaline Bio Inc (TRML)|Bozor kapitallashuvining balans qiymatiga nisbati PGEN|Pharming Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|NKTR: Bozor qiymatining balans qiymatiga nisbati|UPB: Kapitallashuvning sof aktivlarga nisbati|ZBIO (Zenas Biopharma) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|GOSS (Gossamer Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati KALV|Bozor qiymatining balans qiymatiga nisbati Septerna Inc SEPN|Kapitallashuvning balans qiymatiga nisbati pieris.com (PVLA)|SVRA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Rigel Pharma RIGL|AnaptysBio Corp - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS - Bozor kapitallashuvining balans qiymatiga nisbati|enGene Holdings Inc. (ENGN) - Bozor kapitallashuvining balans qiymatiga nisbati|rapt.com (RAPT) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati JBIO|Kapitallashuvning sof aktivlarga nisbati Aclaris Therapeutics Inc.|Kyverna - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti TLSA (Tiziana Life Sciences, Ltd.)|Bozor qiymatining balans qiymatiga nisbati Cabaletta Bio, Inc. CABA|ventyxbio.com - Bozor qiymatining balans qiymatiga nisbati|THTX - Bozor qiymatining balans qiymatiga nisbati|AVTX - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ELDN|AGEN (Agenus, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CLYM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati zurabio.com|Bozor kapitallashuvining balans qiymatiga nisbati ATYR|Bozor kapitallashuvining balans qiymatiga nisbati adagene.com ADAG|Kapitallashuvning sof aktivlarga nisbati Ikena Oncology|Balans qiymatiga nisbatan bozor qiymati Shattuck Labs Inc STTK|EQ - Bozor kapitallashuvining balans qiymatiga nisbati|CNTB - Bozor qiymatining balans qiymatiga nisbati|immunic-therapeutics.com - Bozor kapitallashuvining balans qiymatiga nisbati|ATRA (Atara Bio) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati IFRX (InflaRx NV)|Bozor qiymatining balans qiymatiga koeffitsiyenti XFOR|Bozor qiymatining balans qiymatiga nisbati Adicet Bio (ACET)|Bozor qiymatining balans qiymatiga nisbati CELU (celularity.com)|INMB: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Barinthus Biotherapeutics PLC BRNS|Bozor kapitallashuvining balans qiymatiga nisbati KZR|SABS - Bozor qiymatining xususiy kapitalga nisbati|Akari Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Enlivex Therapeutics Ltd. (ENLV) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati QTTB|Kapitallashuvning sof aktivlarga nisbati GOVX|EDSA (Edesa) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati xtlbio.com XTLB|BOLT - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB - Bozor qiymatining balans qiymatiga nisbati|APVO (aptevotherapeutics.com) - Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|Bozor qiymatining balans qiymatiga nisbati GRI|XRTX - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Vyome Holdings Inc. (HIND)|Bozor kapitallashuvining balans qiymatiga nisbati Revelation Bio|Balans qiymatiga nisbatan bozor qiymati Indaptus Corp INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CALI: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati affimed.com AFMD|ALLK (Allakos) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HOOK|Kapitallashuvning sof aktivlarga nisbati IGM Bio|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati oceanbiomedical.com OCEA|Kapitallashuvning sof aktivlarga nisbati TC BioPharm|Balans qiymatiga nisbatan bozor qiymati Third Harmonic Bio Inc. THRD